Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yvonne L E Ang

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Current Problems in Cancer|June 7, 2017
Development of PARP inhibitors in gynecological malignanciesYvonne L E Ang, David S P Tan
Critical Reviews in Oncology/Hematology|March 8, 2016
Translating gastric cancer genomics into targeted therapiesYvonne L E Ang, Wei Peng Yong, Patrick Tan
Therapeutic Advances in Respiratory Disease|April 24, 2015
Best practice in the treatment of advanced squamous cell lung cancerYvonne L E Ang, Hon-Lyn Tan, Ross A Soo
Primary Care Diabetes|October 5, 2011
Record-based, stepwise screening for type 2 diabetes integrated into an annual cardiovascular care review system: Findings from a UK general practiceBenjamin G Fisher, Yvonne L E Ang, Clare Goodhart, et al.
Expert Review of Anticancer Therapy|February 8, 2026
Integrating liquid biopsies in non-small cell lung cancer diagnosis and management: opportunities and challengesJeong Uk Lim, Yuko Oya, Rui Fu, et al.
Intensive Care Medicine|January 7, 2010
Noninvasive and invasive ventilation in acute respiratory failure associated with bronchiectasisJason Phua, Yvonne L E Ang, Kay Choong See, et al.
Therapeutic Advances in Medical Oncology|December 24, 2025
A cost-effectiveness analysis model of actionable genomic alteration testing strategies incorporating different modalities and sizes of next-generation sequencing panels in non-small-cell lung cancerYvonne L E Ang, Jian Chun Matthew Ong, Yiqing Huang, et al.
BMC Cancer|November 18, 2020
A randomized phase II trial evaluating the addition of low dose, short course sunitinib to docetaxel in advanced solid tumoursYvonne L E Ang, Gwo Fuang Ho, Ross A Soo, et al.
European Journal of Cancer (Oxford, England : 1990)|September 17, 2023
Phase II study of trifluridine/tipiracil in metastatic breast cancers with or without prior exposure to fluoropyrimidinesJoline S J Lim, Samuel G W Ow, Andrea L A Wong, et al.
Cancers|October 28, 2023
A Phase II Study of Osimertinib in Patients with Advanced-Stage Non-Small Cell Lung Cancer following Prior Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR TKI) Therapy with EGFR and T790M Mutations Detected in Plasma Circulating Tumour DNA (PLASMA Study)Yvonne L E Ang, Xiaotian Zhao, Thanyanan Reungwetwattana, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Current Problems in Cancer|June 7, 2017
Development of PARP inhibitors in gynecological malignanciesYvonne L E Ang, David S P Tan
Critical Reviews in Oncology/Hematology|March 8, 2016
Translating gastric cancer genomics into targeted therapiesYvonne L E Ang, Wei Peng Yong, Patrick Tan
Therapeutic Advances in Respiratory Disease|April 24, 2015
Best practice in the treatment of advanced squamous cell lung cancerYvonne L E Ang, Hon-Lyn Tan, Ross A Soo
Primary Care Diabetes|October 5, 2011
Record-based, stepwise screening for type 2 diabetes integrated into an annual cardiovascular care review system: Findings from a UK general practiceBenjamin G Fisher, Yvonne L E Ang, Clare Goodhart, et al.
Expert Review of Anticancer Therapy|February 8, 2026
Integrating liquid biopsies in non-small cell lung cancer diagnosis and management: opportunities and challengesJeong Uk Lim, Yuko Oya, Rui Fu, et al.
Intensive Care Medicine|January 7, 2010
Noninvasive and invasive ventilation in acute respiratory failure associated with bronchiectasisJason Phua, Yvonne L E Ang, Kay Choong See, et al.
Therapeutic Advances in Medical Oncology|December 24, 2025
A cost-effectiveness analysis model of actionable genomic alteration testing strategies incorporating different modalities and sizes of next-generation sequencing panels in non-small-cell lung cancerYvonne L E Ang, Jian Chun Matthew Ong, Yiqing Huang, et al.
BMC Cancer|November 18, 2020
A randomized phase II trial evaluating the addition of low dose, short course sunitinib to docetaxel in advanced solid tumoursYvonne L E Ang, Gwo Fuang Ho, Ross A Soo, et al.
European Journal of Cancer (Oxford, England : 1990)|September 17, 2023
Phase II study of trifluridine/tipiracil in metastatic breast cancers with or without prior exposure to fluoropyrimidinesJoline S J Lim, Samuel G W Ow, Andrea L A Wong, et al.
Cancers|October 28, 2023
A Phase II Study of Osimertinib in Patients with Advanced-Stage Non-Small Cell Lung Cancer following Prior Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR TKI) Therapy with EGFR and T790M Mutations Detected in Plasma Circulating Tumour DNA (PLASMA Study)Yvonne L E Ang, Xiaotian Zhao, Thanyanan Reungwetwattana, et al.
Pageof 2